Two Sigma Securities’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$33.2K Sell
3,162
-493
-13% -$4.81K ﹤0.01% 1311
2025
Q4
$42K Buy
+3,655
New +$56.5K 0.01% 1095
2025
Q3
Sell
-10,154
Closed -$167K 1455
2025
Q2
$167K Buy
+10,154
New +$175K 0.02% 975
2020
Q1
Sell
-325
Closed -$205K 1454
2019
Q4
$205K Buy
+325
New +$159K ﹤0.01% 2078

Other funds holding CDLX

Two Sigma Securities's CDLX Position: Q1 2026 in Review

Two Sigma Securities reduced its Cardlytics (CDLX) stake by 13% in Q1 2026, selling an estimated $4.81K and leaving 3,162 shares worth $33.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1311.

Two Sigma Securities first reported a position in CDLX in Q4 2019 and has held it in 4 quarters since. The position peaked at $205K in Q4 2019. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • Two Sigma Securities held 3,162 shares of Cardlytics worth $33.2K as of Q1 2026.
  • Two Sigma Securities sold 493 Cardlytics shares in Q1 2026, an estimated $4.81K.
  • Cardlytics made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1311 holding.
  • Two Sigma Securities first reported a position in Cardlytics in Q4 2019 and has held it in 4 quarters since.
  • Two Sigma Securities's Cardlytics position peaked at $205K in Q4 2019.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.